Metformin paradoxically worsens insulin resistance in SHORT syndrome.
Krzysztof C LewandowskiKatarzyna DąbrowskaMaria BrzozowskaJoanna KawalecAndrzej LewińskiPublished in: Diabetology & metabolic syndrome (2019)
Metformin treatment may paradoxically lead to deterioration of insulin resistance and to development of glucose intolerance in SHORT syndrome. Hence, metformin treatment might be potentially harmful in these patients. Though, the precise cause of such profound and paradoxical worsening of glucose tolerance post metformin remains unknown, SHORT syndrome might prove to be an interesting model to study the mechanism(s) of metformin action.